Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for July 3rd, 2012

« Older Entries

A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission

By on Tuesday, July 3rd, 2012 | No Comments

Condition :   Leukemia, Myeloid, Acute Intervention :   Biological: CSL362 Sponsors :   CSL Limited;   CSL Limited;   Parexel Not yet recruiting – verified June 2012

Read More...

Vitamin D and Marine Omega-3 Fatty Acids on Anemia

By on Tuesday, July 3rd, 2012 | No Comments

Condition :   Anemia Interventions :   Dietary Supplement: Vitamin D3 (cholecalciferol), 2000 IU per day.;   Dietary Supplement: omega-3 fatty acids (fish oil);   Dietary Supplement: Fish oil placebo;   Dietary Supplement: Vitamin D3 placebo Sponsors :   Brigham and Women’s Hospital;   Brigham and Women’s Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   Office of Dietary Supplements (ODS);   National Center for Complimentary and Alternative Medicine (NCCAM) Not yet recruiting – verified June 2012

Read More...

Identifying Skin Biopsy Sites

By on Tuesday, July 3rd, 2012 | No Comments

Condition :   Identification of Skin Cancer Biopsy Sites Intervention :   Other: Survey/Interview Sponsors :   Northwestern University;   Northwestern University Not yet recruiting – verified June 2012

Read More...

Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment

By on Tuesday, July 3rd, 2012 | No Comments

Condition :   Metastatic Cancer Intervention :   Drug: Pixantrone Sponsors :   Cell Therapeutics;   Cell Therapeutics Active, not recruiting – verified June 2012

Read More...

Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets

By on Tuesday, July 3rd, 2012 | No Comments

Conditions :   Colorectal Cancer;   Liver Metastasis Intervention :   Drug: Bevacizumab, mFOLFOX, FOLFIRI Sponsors :   Yonsei University;   Yonsei University Recruiting – verified June 2012

Read More...

Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis

By on Tuesday, July 3rd, 2012 | No Comments

Condition :   Patients Scheduled for Prostate Biopsy Because of Increased Serum PSA and/or Abnormal Digital Rectal Examination Intervention :   Other: urinary PCA3 test using Progensa® PCA3 assay kit (Gen-Probe) Sponsors :   Hospices Civils de Lyon;   Hospices Civils de Lyon Not yet recruiting – verified June 2012

Read More...

NGPDT – Metastatic Cancer Treatment Patient Interview (Second Treatment Course)

By on Tuesday, July 3rd, 2012 | No Comments

Patient interview during second course of Next Generation PDT for metastatic cancer in lung, lymph node and nasal cavity. Customized non-toxic, minimally intrusive treatment protocol. For more information please see www.NextGenerationPDT.com

Read More...

Amniotic fluid yields alternatives to embryonic stem cells

By on Tuesday, July 3rd, 2012 | No Comments

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a new study. Scientists have succeeded in reprogramming amniotic fluid cells without having to introduce extra genes. The findings raise the possibility that stem cells derived from donated amniotic fluid could be stored in banks and used for therapies and in research, providing a viable alternative to the limited embryonic stem cells currently available.

Read More...

New Brunswick bioscience firm on cusp of cancer breakthrough

By on Tuesday, July 3rd, 2012 | No Comments

Jack Stewart has told the “shrew story” countless times over the past decade. He admits that retelling the tale can sometimes feel monotonous, but it always intrigues his listener.

Read More...

Hot needle that spares men from impotence by destroying cancer cells

By on Tuesday, July 3rd, 2012 | No Comments

The device, which is placed against the diseased prostate gland, uses high temperatures to destroy cancer cells, but leaves the healthy surrounding tissue untouched.

Read More...
« Older Entries